MTOR and prostate cancer: In Group B, except 6 overlapped pathways, the miRNA targets are also associated with gap junction (P = 3.18 × 10−3), melanoma (P = 3.41 × 10−3), hypertrophic cardiomyopathy (P = 9.17 × 10−3), adipocytokine signaling pathway (P = 1.05 × 10−2), mTOR signaling pathway (P = 1.43 × 10−2), prostate cancer (P = 3.73 × 10−2), and glioma (P = 3.04 × 10−2) (Figure 3(d)).